| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/17/2004 | CN1482918A Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 03/17/2004 | CN1482917A New therapeutic uses of smr1 peptides |
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1482909A Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 03/17/2004 | CN1482896A Compositions for prevention and alleviation of skin wrinkles |
| 03/17/2004 | CN1482894A Oral composition providing enhanced tooth stain removal |
| 03/17/2004 | CN1482249A Eukaryotic expression vector of ER-detented IV collagenase cellular antibody gene |
| 03/17/2004 | CN1482140A Process for extracting medicinal protein from ostrich blood and use thereof |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |
| 03/17/2004 | CN1481897A Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use |
| 03/17/2004 | CN1481896A Interferon formulation of skin-infiltrating type |
| 03/17/2004 | CN1481895A Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 03/17/2004 | CN1481894A Drug composition, its preparation method and use |
| 03/17/2004 | CN1481893A Novel use of boninmycin in curing disease resulted from papillomavirus |
| 03/17/2004 | CN1142274C Polypeptide having cell withering promoting activity |
| 03/17/2004 | CN1142182C Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 03/17/2004 | CN1142181C Giant web bombinator polypeptide and its application for preparing anticancer and anti-AIDS medicines |
| 03/17/2004 | CN1142180C Giant web bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 03/17/2004 | CN1142178C Novel peptides and remedy for bone diseases contg. same as active ingredient |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/17/2004 | CN1141981C Sponge material capable of promoting healing of spinal tissue wound, its preparing method and use |
| 03/17/2004 | CN1141974C Oral biologic preparation of colon-positioning release |
| 03/17/2004 | CN1141942C Health-care polypeptide product of nerve and its preparing process |
| 03/16/2004 | US6706947 Method for screening for agents against cancer using an immunosuppression animal model |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706871 Isolated polynucleotide comprising specified nucleotide sequence which encodes polypeptide having specified amino acid sequence |
| 03/16/2004 | US6706870 Nucleic acids encoding CTLA-8; and related reagents |
| 03/16/2004 | US6706869 Map kinase phosphatases and polynucleotides encoding them |
| 03/16/2004 | US6706868 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/16/2004 | US6706862 Backbone-cyclized BPI peptidomimetics |
| 03/16/2004 | US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
| 03/16/2004 | US6706759 Method of treating cancer using dithiocarbamate derivatives |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706691 Bioavailability of compositions metabolized by the gut p450 isozymes |
| 03/16/2004 | US6706690 Hemoactive compositions and methods for their manufacture and use |
| 03/16/2004 | US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction |
| 03/16/2004 | US6706688 Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1 |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706686 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/16/2004 | US6706685 Compounds and methods for stimulating β-catenin mediated gene expression and differentiation |
| 03/16/2004 | US6706682 Increasing or maintaining the blood supply in the penis |
| 03/16/2004 | US6706681 Stabilised with mannitol |
| 03/16/2004 | US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα |
| 03/16/2004 | US6706512 Proteolytically activating protein c, free of fibrinogen cleavage activity |
| 03/16/2004 | US6706509 Serine and threonine kinase activity |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706504 Single chain human tissue-type plasminogen activator protein having r275 and at least one other basic amino acid in serine protease region replaced by non-basic amino acid, disrupting salt bridge interaction between aspartate 477 and lysine 429 |
| 03/16/2004 | US6706496 Method for expression of heterologous proteins in yeast |
| 03/16/2004 | US6706495 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 03/16/2004 | US6706494 Isolated recombinant polypeptide comprising specified amino acid sequence or immunogenic fragment comprising at least 15 contiguous amino acids, which induces antibody- or t-cell mediated immune response that recognizes polypeptide |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706289 Methods and compositions for enhanced delivery of bioactive molecules |
| 03/16/2004 | US6706288 Microparticles |
| 03/16/2004 | US6706284 Bitterness-reduced oral pharmaceutical composition |
| 03/16/2004 | US6706271 Cloning of BASB023 antigen from Moraxella catarrhalis |
| 03/16/2004 | US6706269 Moraxella catarrhalis PILQ proteins |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706264 Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
| 03/16/2004 | US6706262 Compounds and methods for therapy and diagnosis of lung cancer |
| 03/16/2004 | US6706261 Compositions and methods comprising immunogenic muteins of interleukin-6 |
| 03/16/2004 | CA2331446C Biodegradable sustained-release alginate gels |
| 03/16/2004 | CA2223745C Method of solubilizing, purifying, and refolding protein |
| 03/16/2004 | CA2105165C Dosage form for a delayed drug-delivery |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020981A2 Methods of screening cyclic peptides and identifying targets therefor |
| 03/11/2004 | WO2004020979A2 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 03/11/2004 | WO2004020969A2 Production of nanoparticles having a defined number of ligands |
| 03/11/2004 | WO2004020733A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 03/11/2004 | WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 03/11/2004 | WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | WO2004020631A2 Genetic suppression and replacement |
| 03/11/2004 | WO2004020610A2 Methods and compositions for modulating xbp-1 activity |
| 03/11/2004 | WO2004020608A2 Modulators of tnf-alpha and il-1 cell surface receptor activity |
| 03/11/2004 | WO2004020599A2 Hedgehog antagonists, methods and uses related thereto |
| 03/11/2004 | WO2004020596A2 Polypeptides for increasing mutant cftr channel activity |
| 03/11/2004 | WO2004020593A2 Immune response associated proteins |
| 03/11/2004 | WO2004020591A2 Methods of use for novel human polypeptides encoded by polynucleotides |
| 03/11/2004 | WO2004020588A2 Transferrin fusion protein libraries |
| 03/11/2004 | WO2004020586A2 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 03/11/2004 | WO2004020583A2 Polynucleotide predictor set for identifying protein tyrosine kinase modulators |
| 03/11/2004 | WO2004020582A2 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 03/11/2004 | WO2004020581A2 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes |
| 03/11/2004 | WO2004020578A2 Glycosylation modified il-20 |
| 03/11/2004 | WO2004020577A2 Processes for inhibiting gene expression using polynucleotides |
| 03/11/2004 | WO2004020576A2 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 03/11/2004 | WO2004020469A2 Ocular gene therapy |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020466A1 Protein tyrosine phosphatase inhibitors |
| 03/11/2004 | WO2004020465A2 Proteins involved in the regulation of energy homeostasis |
| 03/11/2004 | WO2004020462A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | WO2004020461A1 A group of novel synthetic antibiotic peptides |
| 03/11/2004 | WO2004020460A1 Novel depsipeptide compound |
| 03/11/2004 | WO2004020457A2 Methods and compositions for the inhibition of dna repair protein xrcc-3 |
| 03/11/2004 | WO2004020454A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 03/11/2004 | WO2004020451A1 Group b streptococcal phage lysin |
| 03/11/2004 | WO2004020405A2 Modified transferrin fusion proteins |